Morris Capital Advisors, LLC Eli Lilly & CO Transaction History

Morris Capital Advisors, LLC

$106 Million
Q3 2022

A detailed history of Morris Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Morris Capital Advisors, LLC holds 11,086 shares of LLY stock, worth $8.27 Million. This represents 3.38% of its overall portfolio holdings.

Number of Shares

11,086

Previous 11,210 1.11%

Holding current value

$8.27 Million

Previous $3.64 Million 1.38%

% of portfolio

3.38%

Previous 3.24%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$296.48 - $337.87 $36,763 - $41,895	-124 Reduced 1.11%	11,086 $3.59 Million
Q2 2022 Jul 15, 2022	SELL	$278.73 - $327.27 $3.3 Million - $3.88 Million	-11,845 Reduced 51.38%	11,210 $3.64 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $141,987 - $176,454	-605 Reduced 2.56%	23,055 $6.6 Million
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $78,697 - $97,664	-350 Reduced 1.46%	23,660 $6.54 Million
Q3 2021 Oct 22, 2021	SELL	$221.6 - $272.71 $187,473 - $230,712	-846 Reduced 3.4%	24,010 $5.55 Million
Q2 2021 Jul 15, 2021	SELL	$180.55 - $233.54 $74,386 - $96,218	-412 Reduced 1.63%	24,856 $5.71 Million
Q1 2021 Apr 16, 2021	SELL	$164.32 - $212.72 $105,986 - $137,204	-645 Reduced 2.49%	25,268 $4.72 Million
Q4 2020 Jan 19, 2021	SELL	$130.46 - $172.63 $192,819 - $255,147	-1,478 Reduced 5.4%	25,913 $4.38 Million
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $253,691 - $293,440	-1,735 Reduced 5.96%	27,391 $4.05 Million
Q2 2020 Jul 23, 2020	SELL	$136.42 - $164.18 $236,552 - $284,688	-1,734 Reduced 5.62%	29,126 $4.78 Million
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $108,216 - $133,941	-909 Reduced 2.86%	30,860 $4.28 Million
Q4 2019 Jan 31, 2020	SELL	$106.92 - $132.43 $63,724 - $78,928	-596 Reduced 1.84%	31,769 $4.18 Million
Q3 2019 Oct 21, 2019	SELL	$106.79 - $116.16 $548,580 - $596,713	-5,137 Reduced 13.7%	32,365 $3.62 Million
Q2 2019 Jul 15, 2019	SELL	$110.79 - $129.32 $467,090 - $545,213	-4,216 Reduced 10.11%	37,502 $4.16 Million
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $221,061 - $260,205	-1,986 Reduced 4.54%	41,718 $5.41 Million
Q4 2018 Feb 20, 2019	SELL	$105.9 - $118.64 $131,210 - $146,994	-1,239 Reduced 2.76%	43,704 $5.06 Million
Q3 2018 Oct 31, 2018	SELL	$85.86 - $107.31 $40,354 - $50,435	-470 Reduced 1.03%	44,943 $4.82 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $3.44 Million - $3.95 Million	45,413 New	45,413 $3.88 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morris Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morris Capital Advisors, LLC with notifications on news.

Account

Morris Capital Advisors, LLC Eli Lilly & CO Transaction History